MARSHALL GONZALES: Open Payments
NPI 1952456915 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 9 payments from 6 companies in 2025. Trend: 2023 $276 · 2024 $304 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 3 | $162 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $125 |
| Astellas Pharma US Inc | 2 | $122 |
| Eisai Inc. | 1 | $117 |
| PFIZER INC. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: CABOMETYX, PYLARIFY, Xtandi, Lenvima, PADCEV, Nubeqa.
Industry payments across TX — which companies pay providers there.
